The Progress of Red Blood Cells Based Drug Delivery Systems / 中国输血杂志
Chinese Journal of Blood Transfusion
; (12): 672-676, 2022.
Article
em Zh
| WPRIM
| ID: wpr-1004234
Biblioteca responsável:
WPRO
ABSTRACT
Red blood cells(RBCs), as the most abundant types of blood cells in the blood, have several advantages as a drug delivery system due to their ultra-long circulation half-life, good biocompatibility, and biodegradability. To date, a variety of RBCs-based drug delivery techniques have been developed for the treatment of infection diseases, cancers, chronic diseases, and autoimmune diseases. This review summarized the progress of RBCs related drug delivery systems, and discussed the advantages and disadvantages of different loading methods and their pre-clinical application progress, promoting the research and development of drug delivery.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Blood Transfusion
Ano de publicação:
2022
Tipo de documento:
Article